meRfi®-GM
Chemotherapy (CT) & Gut microbiota
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Modulation by Gut Microbiota
Studies have demonstrated that gut microbiota modifies the effect of chemotherapy (CT).
It Is Known that Gut Microbiota Contribute to the Immune System Activation against Tumors and Response to Chemotherapy
Gut microbiota modulates the activity, efficacy, and toxicity of several chemotherapy agents, such as:
References (Sources)
- 16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation
- Gut microbiome associated with the psychoneurological symptom cluster in patients with head and neck cancers
- Gut microbiota and cancer: how gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
- Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
- Systematic review of agents for the management of gastrointestinal mucositis in cancer patientsReview
- The efficacy and safety of probiotics in people with cancer: a systematic review
- The impact of the host intestinal microbiome on carcinogenesis and the response to chemotherapy